Document:

Employment Agreement between Thomas Caneris and PharMerica Corporation

 Exhibit 10.25 
 EMPLOYMENT AGREEMENT 
 THIS AGREEMENT by and between PharMerica Corporation, a Delaware corporation
(hereinafter the “Company”), and Thomas Caneris (the “Executive”), is effective as of August 17, 2007 (“Start Date”); 
 WHEREAS, the Company is engaged in the institutions pharmacy business; 
 WHEREAS, the Company desires to
employ the Executive, effective as of the Start Date, as the Senior Vice President and General Counsel and Secretary of the Company, and the Executive desires to serve in that capacity, effective as of the date of this Agreement; 
 NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS: 
 1. Employment Period. The Company shall employ the Executive, either directly or through a Subsidiary, and the Executive shall serve the Company or any such Subsidiary, on the terms and conditions set forth in this Agreement, beginning on
the Start Date (the “Employment Date”) and until that employment ceases as provided below in Section 4 (the “Employment Period”). 
 2. Position and Duties. 
 (a) During the Employment Period, the Executive shall be employed as the Senior
Vice President and General Counsel and Secretary of the Company, subject to such changes in title as may be proposed by the Board or the Chief Executive Officer and consented to by the Executive. The Executive shall report to the Chief Executive
Officer of the Company and shall perform such duties for the Company as are related typically to the office of Senior Vice President and General Counsel and Secretary, in the manner reasonably directed by the Chief Executive Officer of the Company,
in his discretion. 
 (b) During the Employment Period, but excluding any periods of vacation and absence due to intermittent illness to
which the Executive is entitled, and any services on corporate, civic or charitable boards or committees, lectures, speaking engagements or teaching engagements that are approved by the Executive’s direct supervisor and that do not
significantly interfere with the performance of the Executive’s responsibilities to the Company or violating the provisions of Section 9, the Executive shall devote his full time and attention during normal business hours to the business
and affairs of the Company and the Executive shall use reasonable efforts to carry out all duties and responsibilities assigned to him faithfully and efficiently. 
 3. Compensation. 
 (a) Base Salary. During the Employment Period, the Executive shall receive an annual base
salary of $250,000.00, payable in accordance with the regular payroll practices of the Company. The Executive’s base salary shall be reviewed annually by the Compensation Committee and/or the Chief Executive Officer of the Company, in
accordance with the Company’s standard practices for executives generally, and may be increased, but not decreased, as determined by the Committee, in its sole discretion, or by any person or persons to whom the Committee has delegated such
authority. 
 (b) Annual Bonus and Incentive Plans; Other Benefits. During the Employment Period: (i) the Executive shall be entitled to
participate in any short-term and long-term incentive programs established and/or maintained by the Company for its senior level executives generally; (ii) the Executive shall be entitled to participate in all incentive, savings and retirement
plans, practices, policies 

 
and programs of the Company to at least the same extent as other senior executives of the Company; (iii) the Executive and/or the Executive’s
family, as the case may be, shall be eligible for participation in, and shall receive all benefits under, all welfare benefit plans, practices, policies and programs provided by the Company to at least the same extent as other senior executives of
the Company; and (iv) the Executive shall be entitled to, and the Company shall provide the Executive with 4 weeks of paid vacation during each calendar year pursuant to the Company’s vacation policy. 
 (c) Expenses. During the Employment Period, the Executive shall be entitled to receive advancement or prompt reimbursement for all reasonable expenses
incurred or anticipated to be incurred by the Executive in carrying out the Executive’s duties under this Agreement, provided that the Executive complies with the generally applicable policies, practices and procedures of the Company for
submission of expense reports, receipts, or similar documentation of such expenses. 
 4. Termination of Employment. 
 (a) Death or Disability. The Executive’s employment and the Employment Period shall terminate automatically upon the Executive’s death or long
term Disability during the Employment Period. “Disability” means a condition entitling the Executive to benefits under the Company’s Long Term Disability Plan, policy or arrangement. 
 (b) By the Company. The Company may terminate the Executive’s employment under this Agreement during the Employment Period for Cause or without
Cause. “Cause” means 
 (i) the continued failure by the Executive to substantially perform his duties as contemplated by this
Agreement (other than any such failure resulting from his incapacity due to physical or mental illness or injury or any such actual or anticipated failure after the issuance by the Executive of a Notice of Termination for Good Reason) over a period
of not less than thirty days after a demand for substantial performance is delivered to the Executive by the Board or by the Chief Executive Officer of the Company, which demand identifies the manner in which it is believed that the Executive has
not substantially performed his duties; 
 (ii) the willful misconduct of the Executive materially and demonstrably injurious to the Company
(including, without limitation, any breach by the Executive of Section 9 of this Agreement); provided that no act or failure to act on the Executive’s part will be considered willful if done, or omitted to be done, by him in good faith and
with reasonable belief that his action or omission was in the best interest of the Company; 
 (iii) the conviction of the Executive for a
misdemeanor, which, as determined in good faith by the Board, constitutes a crime of moral turpitude and gives rise to material harm to the Company or to any subsidiary or affiliate of the Company; 
 (iv) the conviction of the Executive for a felony (including, without limitation, any felony constituting a crime of moral turpitude); or 
 (v) material breach by the Executive of the Executive’s obligations under this Agreement. 
 (c) By the Executive. The Executive may terminate employment under this Agreement for Good Reason or without Good Reason. “Good Reason” means:

 (i) any reduction in the Executive’s Base Salary, incentive bonus opportunity or long-term incentive opportunity; or 
  

 2 

 (ii) material failure by the Company to comply with any provision of Sections 2 and 3 of this Agreement,
other than an isolated, insubstantial or inadvertent failure that is not taken in bad faith and is remedied by the Company within 30 days after receipt of written notice thereof from the Executive. 
 Notwithstanding the foregoing, “Good Reason” for purposes of Section 4(c)(i) shall
not include a reduction in Base Salary, incentive bonus or long-term incentive opportunity if such reduction is coincident with a reduction applicable to all members of the senior management team. A termination of employment by the Executive for
Good Reason shall be effectuated by giving the Company written notice (“Notice of Termination for Good Reason”) of the termination, setting forth in reasonable detail the specific conduct that constitutes Good Reason and the specific
provision(s) of this Agreement on which the Executive relies. Such Notice of Termination for Good Reason must be received by the Company no later than the 60th day after the event, or last in a series of events, that gives rise to Good Reason. The Company shall have 20 days to remedy the conduct set forth in the Notice of Termination for Good Reason. A termination of employment by the Executive
for Good Reason shall be effective on the 60th business day following the date when the Notice of Termination for Good Reason is given, unless the conduct
set forth in the notice is remedied by the Company within the 20-day period. A termination of the Executive’s employment by the Executive without Good Reason shall be effected by giving the Company at least 30 days’ advance written notice
of the termination. 
 (d) Date of Termination. The “Date of Termination” means the date of the Executive’s
death, the date of the Executive’s Disability, the date the termination of the Executive’s employment under this Agreement by the Company for Cause or without Cause or by the Executive for Good Reason or without Good Reason, as the case
may be, is effective. The Employment Period shall end on the Date of Termination. 
 5. Obligations of the Company upon Termination.

 (a) By the Company Other Than for Cause; or By the Executive for Good Reason. If, during the Employment Period, the Company terminates the
Executive’s employment under this Agreement (other than for Cause) or the Executive terminates employment under this Agreement for Good Reason: 
 (1) the Executive shall be entitled to (i) continued payment for eighteen (18) months after the Date of Termination of the Executive’s current base salary (as in effect on the Date of Termination), and
(ii) a bonus equal to the average of the annual bonuses earned by the Executive over the three complete years (or if less than three years, the average bonus earned during such shorter period) preceding the Date of Termination (that is, not
including the bonus year that includes the Date of Termination) to be paid on the first business day at the conclusion of the eighteen month period after the Date of Termination; and 
 (2) for the eighteen (18) month period following the Date of Termination, the Executive will receive waiver of the applicable premium
otherwise payable for COBRA continuation coverage for the Executive, his spouse and eligible dependents (to the extent covered on the Date of Termination) for health, prescription, dental and vision benefits; provided, however, that to the extent
COBRA continuation coverage eligibility expires (unless such expiration is due to eligibility for other group health insurance or Medicare) before the end of such eighteen month period, the Executive will receive payment, on an after-tax basis, of
an amount equal to the premium the Company would have otherwise waived for COBRA coverage. The obligations of the 

  

 3 

 
Company to provide benefits under this Section 5(a)(2) shall terminate on the date of occurrence of the first to occur of any of the following, if any
of the following should occur prior to the end of the eighteen (18) month period: (i) the date of commencement of eligibility of the Executive under the group health plan of any other employer or (ii) the date of commencement of
eligibility of the Executive for Medicare benefits. 
 In addition, the Executive shall be entitled to receive executive level outplacement assistance under
any outplacement assistance program then being maintained by the Company in accordance with the terms of any such program. The Executive shall also become vested in any outstanding options, restricted stock or other equity incentive awards only to
the extent provided for under the terms governing such equity incentive award. The Company shall also pay, or cause to be paid, to the Executive, in a lump sum in cash within 30 days after the Date of Termination (or, in the case of the pro-rated
Annual Bonus Amount, at the time such bonus would otherwise be paid), the Executive’s accrued but unpaid cash compensation (the “Accrued Obligations”), which shall include but not be limited to, (W) the Executive’s base
salary through the Date of Termination that has not yet been paid (X) an amount representing a 100% target bonus for the Executive’s salary grade for the year of termination, multiplied by a fraction, the numerator of which is the number
of days in the current fiscal year through the Date of Termination, and the denominator of which is 365 (the “Annual Bonus Amount”), (Y) any accrued but unpaid vacation pay, and (Z) similar unpaid items that have accrued and as
to which the Executive has become entitled as of the Date of Termination, including declared but unpaid bonuses and unreimbursed employee business expenses; provided, however, that the Company’s obligation to make any payments, or cause any
payments to be made, under this paragraph (a) to the extent any such payment shall not have accrued as of the day before the Date of Termination shall also be conditioned upon the Executive’s execution, and non-revocation, of a written
release, substantially in the form attached hereto as Exhibit 1, of any and all claims against the Company and all related parties with respect to all matters arising out of the Executive’s employment under this Agreement or the termination
thereof (other than any entitlements under the terms of this Agreement to indemnification or under any other plans or programs of the Company in which the Executive participated and under which the Executive has accrued and is due a benefit).

 If any payment, compensation or other benefit provided to the Executive in connection with his employment termination is determined, in whole or in part,
to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code and the Executive is a specified employee as defined in Section 409A(a)(2)(B)(i) and Income Tax Regulations under
Section 409A, no part of such payments shall be paid before the day that is six (6) months plus one (1) day after the Date of Termination (the “New Payment Date”). The aggregate of any payments that otherwise would have been
paid to the Executive during the period between the termination date and the New Payment Date shall be paid to the Executive, without interest, in a lump sum on such New Payment Date. Thereafter, any payments that remain outstanding as of the day
immediately following the New Payment Date shall be paid without delay over the time period originally scheduled, in accordance with the terms of this Agreement. 
 (b) Death or Disability. If the Executive’s employment is terminated by reason of the Executive’s death or Disability during the Employment Period, the Company shall pay the Accrued Obligations to the
Executive or the Executive’s estate or legal representative, as applicable, in a lump sum in cash within 30 days after the Date of Termination. If the Executive’s employment is terminated by reason of the Executive’s death, the
Executive shall also become vested in any outstanding options, restricted stock or other equity incentive awards. If the Executive’s employment is terminated by reason of the Executive’s death or Disability, the Company shall have no
further obligations under this Agreement or otherwise to or with respect to the Executive other than for any entitlements under the terms of any other plans or programs of the Company in which the Executive participated and under which the Executive
has become entitled to a benefit. 
  

 4 

 (c) By the Company for Cause; By the Executive Other than for Good Reason. If the Executive’s
employment is terminated by the Company for Cause during the Employment Period, or the Executive voluntarily terminates employment during the Employment Period, other than for Good Reason, the Company shall pay the Executive, or shall cause the
Executive to be paid, the Executive’s base salary through the Date of Termination that has not been paid and the amount of any declared but unpaid bonuses, accrued but unpaid vacation pay, and unreimbursed employee business expenses, and the
Company shall have no further obligations under this Agreement or otherwise to or with respect to the Executive other than for any entitlements under the terms of any other plans or programs of the Company in which the Executive participated and
under which the Executive has become entitled to a benefit. 
 (d) Termination Pursuant to a Change of Control. If there is a Change of
Control, as defined in Section 5(d)(i) below, during the Employment Period, the provisions of this Section 5(d) shall apply and shall continue to apply throughout the remainder of Employment Period. If, within one (1) year following a
Change of Control, the Executive’s employment is terminated by the Company or the Executive following the occurrence of any of the events listed in Section 5(d)(ii) below or if the Executive’s employment is terminated without cause
(in accordance with Section 5(a) above), the Company shall pay to the Executive (or the Executive’s estate, if applicable) the payments described under Section 5(a) and the Executive shall become vested in any outstanding options,
restricted stock, or other equity incentive award; provided that the Company’s obligation to make any payment, or to permit any vesting of outstanding options, restricted stock, or other equity incentive award as described above, shall be
conditioned upon the Executive’s execution, and non-revocation, of a written release, substantially in the form attached hereto as Exhibit 1. 
 (i) Change of Control shall mean the occurrence of one or more of the following events: 
 (A) any “person” (as such term is used in Sections 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) becomes a “beneficial owner” (as such term is defined in Rule 13d-3
promulgated under the Exchange Act) (other than the Company, any trustee or other fiduciary holding securities under an employee benefit plan of the Company, or any corporation owned, directly or indirectly, by the stockholders of the Company, in
substantially the same proportions as their ownership of stock of the Company), directly or indirectly, of securities of the Company, representing forty percent (40%) or more of the combined voting power of the Company’s then outstanding
securities; or 
 (B) persons who, as of the Effective Date, constituted the Company’s Board of Directors (the
“Incumbent Board”) cease for any reason including, without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to constitute at least a majority of the Board of Directors, provided that any person
becoming a director of the Company subsequent to the Effective Date whose election was approved by at least a majority of the directors then comprising the Incumbent Board shall, for purposes of this Section 5(d), be considered a member of the
Incumbent Board; or 
 (C) the stockholders of the Company approve a merger or consolidation of the Company with any other
corporation or other entity, other than (1) a merger or consolidation which would result in the voting securities of the 

  

 5 

 
Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the
surviving entity) more than forty percent (40%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation or (2) a merger or consolidation
effected to implement a recapitalization of the Company (or similar transaction) in which no “person” (as hereinabove defined) acquires more than forty percent (40%) of the combined voting power of the Company’s then outstanding
securities; or 
 (D) the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement
for the sale or disposition by the Company of all or substantially all of the Company’s assets. 
 (ii) The events
referred to in Section 5(d) above shall be as follows: 
 (A) a reduction of the Executive’s salary other than a
reduction that is (1) is based on the Company’s financial performance or (2) is similar to the reduction made to the salaries provided to all or most other senior executives of the Company; or 
 (B) a significant change in the Executive’s responsibilities and/or duties which constitutes, when compared to the Executive’s
responsibilities and/or duties before the Change of Control, a demotion; or 
 (C) a material loss of title or office; or

 (D) the relocation of the offices at which the Executive is principally employed as of the Change of Control to a location
more than fifty (50) miles from such offices, which relocation is not approved by the Executive. 
 The Executive shall
provide the Company with reasonable notice and an opportunity to cure any of the events listed in Section 5(d)(ii) and shall not be entitled to compensation pursuant to this Section 5(d) unless the Company fails to cure within a reasonable
period. 
 (e) Treatment of Payments Subject to Section 280G. It is the understanding of the Executive and of the Company that certain
payments by the Company to or for the benefit of the Executive under this Agreement or any other agreement or plan, if any, pursuant to which the Executive is entitled to receive payments or benefits may be subject to the provisions of
Section 280G of the Code or any like statutory or regulatory provision relating to parachute payments as such term is defined in section 280G(b)(2) of the Code (a “Parachute Payment”). In general, under Section 280G, a Parachute
Payment is a compensatory payment (including the accelerated vesting of compensatory stock options made upon the occurrence of a change in control of the Company) to the extent that the payment exceeds three times the Executive’s annual
compensation. 
 (i) Reduction of Minimal Parachute Payment. Notwithstanding any other provision of this Agreement or any
such agreement or plan, the amount of the payment pursuant to Section 5(d) hereof or any other payments (a “Change 

  

 6 

 
in Control Payment”) made to the Executive pursuant to a change in control as defined in Section 280G that is treated as a Parachute Payment is
less than 10% of the Change in Control Payment, such Change in Control Payment shall be reduced to an amount such that the Executive will not receive any Parachute Payment. To the extent that such Parachute Payments have been made to or for the
benefit of the Executive, the Executive shall refund such Parachute Payment to the Company with interest thereon at the applicable Federal rate determined under Section 1274(d) of the Code, compounded annually, or at such other rate as may be
required in order that no such payments shall subject to Section 280G or any like statutory or regulatory provision. To the extent that there is more than one method of reducing the payments to bring them within the limitations of said
Section 280G or any like statutory or regulatory provision, the amount of the cash payment you are otherwise entitled to receive under the terms of this Employment Agreement will be reduced to an amount that prevents the 280G limitation from
being exceeded (but not below zero) 
 (ii) (ii) Payment of Tax Gross-Up for Substantial Parachute Payments. In the event
that (i) the Company makes a Change in Control Payment to the Executive under this Agreement or under any other arrangement that is determined to constitute a Parachute Payment and (ii) the amount of such Parachute Payment is 10% or more
of the Change in Control Payment, the provisions of Section 5(e)(i) shall not apply to such Parachute Payment and the Company shall pay to the Executive, prior to the time any excise tax imposed by section 4999 of the Code (“Excise
Tax”) is payable with respect to such Payment, an additional amount (the “Gross-Up Payment”) which, after the imposition of all income and excise taxes thereon (and assuming all federal, state and other income taxes are imposed at the
highest marginal rate), is equal to the Excise Tax on such Payment. 
 (iii) Determination of Parachute Payment Status. The
determination of whether any Payment constitutes a Parachute Payment and, if so, the amount, if any, to be paid by the Executive to the Company under Section 5(e)(i) hereof or to the Executive by the Company under Section 5(e)(ii) hereof
and the time of payment pursuant to this Section 5(e) shall be made by a nationally-recognized independent accounting firm (the “Auditor”) selected and paid for by the Company. Any Gross-Up Payment shall be paid by the Company to the
Executive no later than ten calendar days after the receipt of the Auditor’s determination. Any determination by the Auditor shall, subject to the provisions of Section 11(c)(ii) and (iii) below, be binding upon the Company and the
Executive. 
 (iv) As a result of uncertainty in the application of sections 280G and 4999 of the Code, or other
circumstances, at the time of the initial determination by the Auditor hereunder, it is possible that the Gross-Up Payment made will have been an amount more than the Company should have paid pursuant to Section 5(e) (the
“Overpayment”) or that the Gross-Up Payment made will have been an amount less than the Company should have paid pursuant to Section 5(e) (the “Underpayment”). In the event that there is a final determination by the Internal
Revenue Service, or a final determination by a court of competent jurisdiction, with respect to the Executive’s liability under section 4999 of the Code such that an Overpayment has been made, then to the extent permitted by applicable law, the
Executive agrees to return to the Company the amount of the Overpayment that the Executive recovers. In the event that there is a final determination by the Internal Revenue Service, or a final determination by a court of competent jurisdiction with
respect to 

  

 7 

 
the Executive’s liability under section 4999 of the Code such that an Underpayment arises under this Letter Agreement, then any such Underpayment shall
be promptly paid by the Company to or for the benefit of the Executive. 
 (v) The Executive agrees to notify the Company in
writing of any claim by the Internal Revenue Service that, if successful, would result in a determination that an Overpayment or an Underpayment had occurred. Such notification shall be given as soon as practicable but no later than 10 business days
after the Executive is informed in writing of such claim and shall apprise the Company of the nature of such claim. In the case of a claim that would result in an Underpayment, such notice shall include the date on which such claim is requested to
be paid. The Executive shall not pay such claim prior to the expiration of the 30 calendar day period following the date on which the Executive gives such notice to the Company (or such shorter period ending on the date that any payment of taxes
with respect to such claim is due). If the Company notifies the Executive in writing prior to the expiration of such period that it desires to contest such claim, the Executive shall cooperate with the Company provided that the Company shall bear
and pay directly all costs and expenses (including, without limitation, attorneys fees, additional interest and penalties) incurred in connection with such contest. 
 6. Non-exclusivity of Rights. Nothing in this Agreement shall prevent or limit the Executive’s continuing or future participation in any plan, program, policy or practice provided by the Company for which the
Executive may qualify. Vested benefits and other amounts that the Executive is otherwise entitled to receive on or after the Date of Termination under any plan, policy, practice or program of, or any contract or agreement with, the Company shall be
payable in accordance with such plan, policy, practice, program, contract or agreement, as the case may be, except as explicitly modified by this Agreement. 
 7. No Mitigation. In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this
Agreement and such amounts shall not be reduced, regardless of whether the Executive obtains other employment. 
 8. Confidential
Information; Non-solicitation; Non-competition. 
 (a) The Executive agrees and acknowledges that by reason of his employment by and service
to the Company, he will have access to, become exposed to and/or become knowledgeable about confidential information of the Company (the “Confidential Information”) from time to time during the Employment Period, including, without
limitation, proposals, plans, inventions, practices, systems, programs, processes, methods, techniques, research, records, supplier sources, customer lists and other forms of business information that are not known to the Company’s competitors,
are not recognized as being encompassed within standard business or management practices and/or are kept secret and confidential by the Company. Executive agrees that at no time during or after the Employment Period will he disclose or use the
Confidential Information except as may be required in the prudent course of business for the benefit of the Company. The Executive also agrees to be subject to the Company’s Code of Ethics and Business Conduct as in effect from time to time
during the Employment Period. 
 (b) The Executive acknowledges that the Company is generally engaged in business throughout the United
States. During the Executive’s employment by the Company and for eighteen (18) months after the Date of Termination or the expiration of the final Employment Period, the Executive agrees that he will not, unless acting with the prior
written consent of the Company, directly or 

  

 8 

 
indirectly, own, manage, control, or participate in the ownership, management or control of, or be employed or engaged by, or otherwise affiliated or
associated with, as an officer, director, employee, consultant, independent contractor or otherwise, any other corporation, partnership, proprietorship, firm, association or other business entity, or otherwise engage in any business, which is
engaged in hospital and long term care institutional pharmacy services; provided, however, that the ownership of not more than 5% of the equity of a publicly traded entity shall not be deemed to be a violation of this paragraph. During such eighteen
month period, Executive also agrees to make himself reasonably available to the Company for consulting at a per diem rate that reflects his annual salary as in an effect prior to his termination of employment (plus reimbursement of Executive’s
reasonable expenses). 
 (c) The Executive also agrees that he will not, directly or indirectly, during the period described in paragraph
(b) of this Section 8 induce any person who is an employee, officer, director, or agent of the Company, to terminate such relationship, or employ, assist in employing or otherwise be associated in business with any present or former
employee or officer of the Company, including without limitation those who commence such positions with the Company after the Date of Termination. 
 (d) The Executive also agrees that he will not, directly or indirectly, during the period described in paragraph (b) of this Section 8, (i) solicit or otherwise accept business for hospital and long term care institutional
pharmacy services from any client or customer of the Company or any prospective client or customer of the Company or (ii) cause a client or customer, or any prospective client or customer of the Company, to terminate or otherwise modify
adversely its business relationship with the Company. 
 (e) The Executive acknowledges and agrees that the restrictions contained in this
Section 8 are reasonable and necessary to protect and preserve the legitimate interests, properties, goodwill and business of the Company, that the Company would not have entered into this Agreement in the absence of such restrictions and that
irreparable injury will be suffered by the Company should the Executive breach the provisions of this Section. The Executive represents and acknowledges that (i) the Executive has been advised by the Company to consult the Executive’s own
legal counsel in respect of this Agreement, (ii) the Executive has consulted with and been advised by his own counsel in respect of this Agreement, and (iii) the Executive has had full opportunity, prior to execution of this Agreement, to
review thoroughly this Agreement with the Executive’s counsel. 
 (f) The Executive further acknowledges and agrees that a breach of the
restrictions in this Section 8 will not be adequately compensated by monetary damages. The Executive agrees that actual damage may be difficult to ascertain and that, in the event of any such breach, the Company shall be entitled to injunctive
relief in addition to such other legal or equitable remedies as may be available to the Company. In the event that the provisions of this Section 8 should ever be adjudicated to exceed the limitations permitted by applicable law in any
jurisdiction, it is the intention of the parties that the provision shall be amended such that those provisions are made consistent with the maximum limitations permitted by applicable law, that such amendment shall apply only within the
jurisdiction of the court that made such adjudication and that those provisions otherwise be enforced to the maximum extent permitted by law. 
 (g) To the extent that any court action is permitted consistent with or to enforce Section 9 of this Agreement, the Executive agrees that suit may be brought, and that he consents to personal jurisdiction, in the United States District
Court for the Eastern District of Kentucky, or if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Fayette County, Kentucky; consents to the non-exclusive jurisdiction of any such court
in any such suit, action or proceeding; and waives any objection which he may have to the laying of venue of any such suit, action or proceeding in any such court. The Executive also irrevocably and unconditionally consents to the service of any
process, pleadings, notices or other papers. 
  

 9 

 (h) For purposes of this Section 8, the term “Company” shall be deemed to include
subsidiaries and affiliates of the Company. 
 (i) The Executive agrees that during his employment he shall not use or disclose to the
Company any confidential or proprietary information obtained in the course of employment with a prior employer. 
 9. Arbitration of
Disputes. Any controversy or claim arising out of or relating to this Agreement or the breach thereof or otherwise arising out of the Executive’s employment or the termination of that employment (including, without limitation, any claims of
unlawful employment discrimination whether based on age or otherwise) shall, to the fullest extent permitted by law, be settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an agreement, under the
auspices of the American Arbitration Association (“AAA”) in Lexington, Kentucky in accordance with the Employment Dispute Resolution Rules of the AAA, including, but not limited to, the rules and procedures applicable to the selection of
arbitrators. In the event that any person or entity other than the Executive or the Company may be a party with regard to any such controversy or claim, such controversy or claim shall be submitted to arbitration subject to such other person or
entity’s agreement. Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. This Section 9 shall be specifically enforceable. Notwithstanding the foregoing, this Section 9 shall not
preclude either party from pursuing a court action for the sole purpose of obtaining a temporary restraining order or a preliminary injunction in circumstances in which such relief is appropriate; provided that any other relief shall be pursued
through an arbitration proceeding pursuant to this Section 9. 
 10. Successors. This Agreement is personal to the Executive and,
without the prior written consent of the Company, shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive’s legal
representatives. This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business and/or assets of the Company expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would have been required to perform it if no such succession had
taken place. As used in this Agreement, “Company” shall mean both the Company as defined above and any such successor that assumes and agrees to perform this Agreement, by operation of law or otherwise. 
 11. Miscellaneous. 
 (a) This
Agreement shall be governed by, and construed in accordance with, the laws of the State of Kentucky, without reference to principles of conflict of laws. The captions of this Agreement are not part of the provisions hereof and shall have no force or
effect. This Agreement may not be amended or modified except by a written agreement executed by the parties hereto or their respective successors and legal representatives. 
 (b) If a claim or action at law or in equity is commenced to enforce or interpret the terms of this Agreement, including any claim or
action pursuant to Section 8, and such claim or action is determined by the presiding fact-finder to be unreasonable, the prevailing party shall be entitled to recover, in addition to any other relief, all attorney’s fees incurred by such
prevailing party. 
  

 10 

 (c) All notices and other communications under this Agreement shall be in writing and
shall be given by hand to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
 If to the Executive, to the address on file with the Company. 
 If to the Company:

 PharMerica Corporation 
 1901 Campus Place, Louisville, KY 40299 
 or to such other address as either party furnishes to the other in
writing in accordance with this paragraph (c) of Section 11. Notices and communications shall be effective when actually received by the addressee. 
 (d) The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement. If any provision of this Agreement shall be held invalid or unenforceable in part, the remaining portion of such provision, together with all other provisions of this Agreement, shall remain valid and enforceable and
continue in full force and effect to the fullest extent consistent with law. 
 (e) Notwithstanding any other provision of
this Agreement, the Company may withhold from amounts payable under this Agreement all federal, state, local, and foreign taxes that are required to be withheld by applicable laws or regulations. 
 (f) The Executive’s or the Company’s failure to insist upon strict compliance with any provision of, or to assert any right
under, this Agreement (including, without limitation, the right of the Executive to terminate employment for Good Reason pursuant to paragraph (c) of Section 5 of this Agreement) shall not be deemed to be a waiver of such provision or
right or of any other provision of or right under this Agreement. 
 (g) Anything to the contrary herein notwithstanding, all
benefits or payments provided by the Company to the Executive that would be deemed to constitute “nonqualified deferred compensation” within the meaning of Section 409A are intended to comply with Section 409A of the Code. If,
however, any such benefit or payment is deemed to not comply with Section 409A of the Code, the Company and the Executive agree to renegotiate in good faith any such benefit or payment (including, without limitation, as to the timing of any
severance payments payable hereof) so that either (i) Section 409A of the Code will not apply or (ii) compliance with Section 409A will be achieved. 
 (h) This Agreement constitutes the entire agreement between the parties with respect to the subject matter of the Agreement and supercedes
all prior agreements between the parties with respect to any related subject matter. 
 (i) This Agreement may be executed in
several counterparts, each of which shall be deemed an original, and said counterparts shall constitute but one and the same instrument. 
 12. The respective rights and obligations of the parties hereunder shall survive any termination of the Executive’s employment to the extent necessary to the intended preservation of such rights and obligations, including, but not by
way of limitation, those rights and obligations set forth in Sections 3, 5, 6, 8, 9, and 11. 
 {SIGNATURE ON NEXT PAGE} 
  

 11 

 IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the
authorization of the Committee, the Company has caused this Agreement to be executed in its name on its behalf, all as of the day and year first above written. 
  

					
		 	SAFARI HOLDING CORPORATION
			
		 	By:	 	 /s/ Gregory S. Weishar

		 	Name:	 	Gregory S. Weishar
		 	Title:	 	Chief Executive Officer

  

			
		 	EXECUTIVE
		
		 	 /s/ Thomas Caneris

		 	Thomas Caneris

  

 12 

 EXHIBIT 1 
 SEPARATION OF EMPLOYMENT AGREEMENT 
 AND GENERAL RELEASE 
 THIS SEPARATION OF EMPLOYMENT AGREEMENT AND GENERAL RELEASE (the “Agreement”) is made as of this     day of
            ,             , by and between PharMerica Corporation (the “Company”) and
                                        
(the “Executive”). 
 WHEREAS, Executive formerly was employed as
            ; 
 WHEREAS, Executive and Company entered into an Employment
Agreement, dated                  ,             , (the “Employment Agreement”)
which provides for certain severance benefits in the event that Executive’s employment is terminated on account of a reason set forth in the Employment Agreement; 
 WHEREAS, Executive and the Company mutually desire to terminate Executive’s employment on an amicable basis, such termination to be effective
                 ,              (the “Date of Resignation”); and 

WHEREAS, in connection with the termination of Executive’s employment, the parties have agreed to a separation package and the resolution of any
and all disputes between them. 
 NOW, THEREFORE, IT IS HEREBY AGREED by and between Executive and the Company as follows: 
 1. (a) Executive, for and in consideration of the commitments of the Company as set forth in Paragraph 5 of this Agreement, and intending to be legally
bound, does hereby REMISE, RELEASE AND FOREVER DISCHARGE the Company, its affiliates, subsidiaries and parents, and its officers, directors, employees, and agents, and its and their respective successors and assigns, heirs, executors, and
administrators (each, a “Releasee” and collectively, “Releasees”) from all causes of action, suits, debts, claims and demands whatsoever in law or in equity, which Executive ever had, now has, or hereafter may have, whether known
or unknown, or which Executive’s heirs, executors, or administrators may have, by reason of any matter, cause or thing whatsoever, from the beginning of Executive’s employment to the date of this Agreement, and particularly, but without
limitation of the foregoing general terms, any claims arising from or relating in any way to Executive’s employment relationship with the Company and/or its predecessors, subsidiaries or affiliates, the terms and conditions of that employment
relationship, and the termination of that employment relationship, including, but not limited to, any claims arising under the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act (“OWBPA”), Title VII of The Civil
Rights Act of 1964, the Americans with Disabilities Act, the Family and Medical Leave Act of 1993, the Employee Retirement Income Security Act of 1974, the Kentucky Civil Rights Act, and any other claims under any federal, state or local common law,
statutory, or regulatory provision, now or hereafter recognized, and any claims for attorneys’ fees and costs. This Agreement is effective without regard to the legal nature of the claims raised and without regard to whether any such claims are
based upon tort, equity, implied or express contract or discrimination of any sort. 
 (b) To the fullest extent permitted by law, and
subject to the provisions of Paragraph 10 below, Executive represents and affirms that (i) Executive has not filed or caused to be filed on Executive’s behalf any claim for relief against the Company or any Releasee and, to the best of
Executive’s knowledge and belief, no outstanding claims for relief have been filed or asserted against the 

  

 13 

 
Company or any Releasee on Executive’s behalf; (ii) Executive has not reported any improper, unethical or illegal conduct or activities to any
supervisor, manager, department head, human resources representative, agent or other representative of the Company, to any member of the Company’s legal or compliance departments, or to the ethics hotline, and has no knowledge of any such
improper, unethical or illegal conduct or activities; and (iii) Executive will not file, commence, prosecute or participate in any judicial or arbitral action or proceeding against the Company or any Releasee based upon or arising out of any
act, omission, transaction, occurrence, contract, claim or event existing or occurring on or before the date of this Agreement. 
 (c)
Nothing in the Agreement will be deemed to release the Company from (i) claims solely to enforce this Agreement, (ii) claims for indemnification under the Company’s By-Laws, or (iii) claims for payment or reimbursement pursuant
to any employee benefit plan, policy or arrangement of the Company. 
 2. In consideration of the Company’s agreements as set forth in
Paragraph 5 herein, Executive agrees to be bound by the terms of Section 9 of the Employment Agreement. 
 3. Executive agrees and
recognizes that Executive has permanently and irrevocably severed Executive’s employment relationship with the Company, that Executive shall not seek employment with the Company or any affiliated entity at any time in the future, and that the
Company has no obligation to employ Executive in the future. 
 4. Executive further agrees that Executive will not disparage or subvert the
Company, or make any statement reflecting negatively on the Company, its affiliated corporations or entities, or any of their officers, directors, employees, agents or representatives, including, but not limited to, any matters relating to the
operation or management of the Company, Executive’s employment and the termination of Executive’s employment, irrespective of the truthfulness or falsity of such statement. The Company agrees that none of its officers, directors,
employees, agents or representatives will disparage or subvert the Executive, or make any statement reflecting negatively on the Executive, including, but not limited to, any matters relating to the Executive’s performance or the termination of
Executive’s employment, irrespective of the truthfulness or falsity of such statement. 
 5. In consideration for Executive’s
agreement as set forth herein, the Company agrees that the Company shall provide the following: 
 (a) The severance benefits
described in Section 5 of the Employment Agreement; and 
 (b) The Company will maintain, for no less than 6 years
following the Date of Resignation, directors’ and officers’ liability insurance covering the Executive’s potential liability in connection with his employment by the Company in amounts and on terms that are commensurate with the
coverage provided to its active officers and directors of the Company. 
 6. Executive understands and agrees that the payments, benefits and
agreements provided in this Agreement are being provided to Executive in consideration for Executive’s acceptance and execution of, and in reliance upon Executive’s representations in, this Agreement. Executive acknowledges that if
Executive had not executed this Agreement containing a release of all claims against the Company, Executive would only have been entitled to the payments provided in the Company’s standard severance pay plan for employees. 
  

 14 

 7. Executive acknowledges and agrees that the Company previously has satisfied any and all obligations
owed to Executive under any employment agreement or offer letter Executive has with the Company and, further, that this Agreement supersedes any employment agreement or offer letter Executive has with the Company, and any and all prior agreements or
understandings, whether written or oral, between the parties shall remain in full force and effect to the extent not inconsistent with this Agreement, and further, that, except as set forth expressly herein, no promises or representations have been
made to Executive in connection with the termination of Executive’s employment agreement or offer letter with the Company, or the terms of this Agreement. 
 8. Executive agrees not to disclose the terms of this Agreement to anyone, except Executive’s spouse, attorney and, as necessary, tax/financial advisor. Likewise, the Company agrees that the terms of this
Agreement will not be disclosed except as may be necessary to obtain approval or authorization to fulfill its obligations hereunder or as required by law. It is expressly understood that any violation of the confidentiality obligation imposed
hereunder constitutes a material breach of this Agreement. 
 9. Executive represents that Executive does not presently have in
Executive’s possession any records and business documents, whether on computer or hard copy, and other materials (including but not limited to computer disks and tapes, computer programs and software, office keys, correspondence, files,
customer lists, technical information, customer information, pricing information, business strategies and plans, sales records and all copies thereof) (collectively, the “Corporate Records”) provided by the Company and/or its predecessors,
subsidiaries or affiliates or obtained as a result of Executive’s prior employment with the Company and/or its predecessors, subsidiaries or affiliates, or created by Executive while employed by or rendering services to the Company and/or its
predecessors, subsidiaries or affiliates. Executive acknowledges that all such Corporate Records are the property of the Company. In addition, Executive shall promptly return in good condition any and all beepers, credit cards, cellular telephone
equipment, business cards and computers. As of the Date of Resignation, the Company will make arrangements to remove, terminate or transfer any and all business communication lines including network access, cellular phone, fax line and other
business numbers. 
 10. Nothing in this Agreement shall prohibit or restrict Executive from: (i) making any disclosure of information
required by law; (ii) providing information to, or testifying or otherwise assisting in any investigation or proceeding brought by, any federal regulatory or law enforcement agency or legislative body, any self-regulatory organization, or the
Company’s General Counsel or Human Resources Director; or (iii) filing, testifying, participating in or otherwise assisting in a proceeding relating to an alleged violation of any federal, state or municipal law relating to fraud, or any
rule or regulation of the Securities and Exchange Commission or any self-regulatory organization. 
 11. The parties agree and acknowledge
that the agreement by the Company described herein, and the settlement and termination of any asserted or unasserted claims against the Releasees, are not and shall not be construed to be an admission of any violation of any federal, state or local
statute or regulation, or of any duty owed by any of the Releasees to Executive. 
 12. Executive agrees and recognizes that should Executive
breach any of the obligations or covenants set forth in this Agreement, the Company will have no further obligation to provide Executive with the consideration set forth herein, and will have the right to seek repayment of all consideration paid up
to the time of any such breach. Further, Executive acknowledges in the event of a breach of this Agreement, Releasees may seek any and all appropriate relief for any such breach, including equitable relief and/or money damages, attorney’s fees
and costs. 
  

 15 

 13. Executive further agrees that the Company shall be entitled to preliminary and permanent injunctive
relief, without the necessity of proving actual damages, as well as to an equitable accounting of all earnings, profits and other benefits arising from any violations of this Agreement, which rights shall be cumulative and in addition to any other
rights or remedies to which the Company may be entitled. 
 14. This Agreement and the obligations of the parties hereunder shall be
construed, interpreted and enforced in accordance with the laws of the State of Kentucky. 
 15. Executive certifies and acknowledges as
follows: 
 (a) That Executive has read the terms of this Agreement, and that Executive understands its terms and effects, including the fact
that Executive has agreed to RELEASE AND FOREVER DISCHARGE the Company and each and everyone of its affiliated entities from any legal action arising out of Executive’s employment relationship with the Company and the termination of that
employment relationship; 
 (b) That Executive has signed this Agreement voluntarily and knowingly in exchange for the consideration
described herein, which Executive acknowledges is adequate and satisfactory to Executive and which Executive acknowledges is in addition to any other benefits to which Executive is otherwise entitled; 
 (c) That Executive has been and is hereby advised in writing to consult with an attorney prior to signing this Agreement; 
 (d) That Executive does not waive rights or claims that may arise after the date this Agreement is executed; 
 (e) That the Company has provided Executive with a period of twenty-one (21) days within which to consider this Agreement, and that Executive has
signed on the date indicated below after concluding that this Agreement is satisfactory to Executive; and 
 (f) Executive acknowledges that
this Agreement may be revoked by Executive within seven (7) days after execution, and it shall not become effective until the expiration of such seven day revocation period. In the event of a timely revocation by Executive, this Agreement will
be deemed null and void and the Company will have no obligations hereunder. 
 [SIGNATURE PAGE FOLLOWS] 
  

 16 

 Intending to be legally bound hereby, Executive and the Company executed the foregoing Separation of
Employment Agreement and General Release this      day of             ,             .

  

											
	  
	 		 	Witness:	  	  
	  	
	 [Executive]
	 		 		  		  	
					
	 PHARMERICA CORPORATION
	 		 		  		  	
						
	 By:
	 	  
	 		 	Witness:	  	  
	  	
	 Name:
	 	  
	 		 		  		  	
	 Title:
	 	  
	 		 		  		  	

  

 17Form Performance Share Award Agreement

 Exhibit 10.26 
 PHARMERICA CORPORATION 
 PharMerica Corporation 2007 Omnibus Incentive Plan 
 Performance Share Award Agreement 
 This PERFORMANCE SHARE AWARD AGREEMENT (the “Agreement”), granted under the PharMerica Corporation 2007 Omnibus Incentive Plan (the “Plan”) is effective as of
             200   (the “Date of Grant”) and is made between PharMerica Corporation, a Delaware corporation (the “Company”) and
                     (the “Recipient”). 
 Preliminary Statements 
 WHEREAS, the Company has determined that it is desirable and in its
best interests to grant to the Recipient shares of the Company’s common stock (the “Stock”) subject to performance conditions, in order to provide the Recipient with a significant interest in the Company’s growth so that the
Recipient will have a greater incentive to perform at the highest level and further the interests of the Company and the shareholders of the Company (the “Award”); and 
 WHEREAS, any capitalized term not herein defined shall have the meaning as set forth in the Plan. 
 NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein: 
 1. Grant of Performance Shares. On the terms and conditions of this Agreement and the Plan, the Committee grants to the Recipient a
performance share award based on the criteria established by the Compensation Committee that are described in Section 2 below (the “Performance Shares”). The target number of Performance Shares to be issued pursuant to the Award is
                 shares (the “Target Shares”) and the maximum number of Performance Shares that may be issued pursuant to the Award is
                 shares. The extent to which the Award shall become vested and non-forfeitable shall be determined in accordance with the provisions of Section
below. The date of grant of the Award is             , 20     (the “Grant Date”). 
 The Recipient’s right, if any, to continue to be employed by the Company will not be enlarged or otherwise affected by the receipt of this Award,
and the receipt of this Award will not in any way restrict the right of the Company to terminate the Recipient’s employment at any time. 
 2. Vesting of the Performance Shares. Except as provided in Section 3 below, the Recipient shall vest in the Award in accordance with the following provisions: 
 (a) Performance Cycle. The Performance Cycle for the Award shall commence on the Grant Date and shall end on the final day of the
Company’s 20     fiscal year (December 31, 20    ). 

 (b) Percentage of Target Shares Earned. Subject to Section 4 below, the extent to which
the Award shall become earned at the end of the Performance Cycle shall be based upon the cumulative annual growth in EBITDA (“EBITDA CAGR”) through the Performance Cycle (the “Performance Criteria”), which shall be determined by
taking the Company’s EBITDA for the Company’s 2007 fiscal year and measuring it against the Company’s EBITDA for the Company’s 2009 fiscal year. The Recipient shall be entitled to 100% of the Target Shares if the Company has
achieved EBITDA CAGR of 20% at the end of the Performance Cycle (equal to a 44% increase in EBITDA by the completion of the Performance Cycle). Generally, the percentage of Target Shares earned at the end of the Performance Cycle based on the
Performance Criteria shall be determined according to the following schedule, however the actual Awards of Performance Shares will be interpolated between the percentages set forth in the chart based on actual results, as provided in Exhibit A
hereto: 
  

			
	 Performance
Criteria
	 	 Payout Level

	 
	Target Performance Achievement	 	(percentage of Target Shares earned)
	< 90%	 	0%
	90%	 	50%
	100%	 	100%
	110%	 	120%
	120%	 	150%
	> 120%	 	150%

 (c) Board Certification. Promptly after the Audit Committee of the Board approves the
Company’s financial statements for the fiscal year in which the end of the Performance Cycle occurs, the Committee must determine and certify whether, and to what extent, the Performance Criteria have been achieved. If the minimum
Performance Criteria of EBITDA CAGR has not been achieved during the Performance Cycle, no Performance Shares will be issued and this Agreement will be of no force or effect. 
 (d) Vesting. The Recipient shall vest in the Award on the last day of the Performance Cycle (the “Vesting Date”); provided,
however, that, unless otherwise provided in Section 3 below, the Recipient remains in the continuous employment of the Company through the Vesting Date. All vesting in the Award, if applicable, shall occur only on the Vesting Date; there
shall be no proportionate vesting in the Award prior to the Vesting Date. 
 3. Acceleration of Vesting of the Award. Upon the
occurrence of any of the following events, the Recipient shall become fully vested in a pro-rata portion of the Award (as determined under Section 3(c) below: 
 (a) the termination of the Recipient’s employment with the Company by reason of the Recipient’s death or disability (within the meaning of Section 409A of the Code), or the Recipient’s
“Retirement” (as defined in Section 3(d) below) from the Company at or after age 62; or 
  

 2 

 (b) within one (1) year following a Change in Control, (A) the Recipient’s
employment is terminated by the Company without “Cause” (as defined in Section 3(d) below) or (B) the Recipient terminates employment for “Good Reason” (as defined in Section 3(d) below) and provided that the
Recipient executes a non-revocable written release in the form provided by the Company or its successors. 
 (c) Calculation of Pro-Rata
Accelerated Shares. The actual number of Performance Shares that shall be paid upon the occurrence of an event specified in this Section 3 is the amount of Performance Shares as determined and certified under Sections 2(b) and 2(c),
respectively, as if the Recipient were still employed on the Vesting Date, multiplied by a fraction; the numerator of which is the total number of complete months worked by the Recipient during the Performance Cycle, and the denominator of which is
            , the total number of months in the Performance Cycle. 
 (d) Definitions. For purposes hereof, the following definitions shall apply: 
 (i) “Retirement” shall mean a
termination of the Optionee’s employment at or after age 62 for any reason except by the Company for Cause; provided, that the Recipient has been employed by the Company for at least five years. 
 (ii) “Good Reason” shall mean either: 
 (A) a reduction of the Recipient’s salary other than (i) a reduction based on the Company’s financial performance, or (ii) a reduction made to the salaries provided to all or most of the other management or executive
employees of the Company with similar responsibilities, positions, compensation or other criteria as determined by the Committee in good faith; 
 (B) a significant change in the Recipient’s responsibilities and/or duties which constitutes, when compared to the Recipient’s responsibilities and/or duties before the Change of Control, a demotion; or a material loss of title or
office; or 
 (C) the relocation of the offices at which the Recipient is principally employed as of the Change of Control to a location
more than fifty (50) miles from such offices, which relocation is not approved by the Recipient. 
 (iii) “Cause” means:

 (A) any willful, material violation of any law or regulation applicable to the business of the Company; 
 (B) conviction for, or guilty plea to, a felony or a crime involving moral turpitude, or any willful perpetration of a common law fraud; 
  

 3 

 (C) commission of any act of personal dishonesty which involves personal profit in connection with the
Company; 
 (D) intentional wrongful disclosure of confidential information of the Company; 
 (E) intentional wrongful engagement in any competitive activity, 
 (F) the willful and continued failure or refusal to perform the material duties required of the Recipient as an employee, officer, director or consultant of the Company (other than as a result of disability);

 (G) disregard of the policies of the Company so as to cause material loss, damage or injury to the property, reputation or employees of
the Company; 
 (H) ongoing alcohol/drug addiction and a failure by the Recipient to successfully complete a recovery program, or

 (I) any other misconduct by the Recipient which is materially injurious to the financial condition or business reputation of, or is
otherwise materially injurious to, the Company. 
 4. Forfeiture of the Award. Any portion of the Award that is
unvested shall automatically be forfeited on the date that the Recipient ceases to be employed by the Company. 
 5. Payment of
Award. The Recipient shall be entered as the stockholder of record for the number of Performance Shares covered by the Award which the Committee determines, in writing, have been vested and earned by the Recipient pursuant to Sections 2(b)
and 2(c) as soon as administratively practicable after the Vesting Date, but no later than March 15th of the year following the year in which the Vesting Date occurs. 
 6. Dividend Equivalent Rights. If any Performance Shares are awarded to the Recipient pursuant to this Agreement, then the Recipient shall
also be entitled to receive a number of shares of Stock equal to (A) (i) the number of Performance Shares awarded to the Recipient under Section 2 multiplied by (ii) the cumulative amount of cash dividends paid by the Company
that the Recipient would have received had he owned the awarded Performance Shares on each dividend record date during the Performance Cycle, divided by (B) the closing price of the Stock on the Vesting Date; provided, however, that cash will
be paid in lieu of any fractional shares the Recipient would be entitled to receive under this Section 6. 
 7. Tax Payment Upon
Vesting. 
 (a) At such time as the Recipient is entered as the stockholder of record with respect to the Performance Shares
earned pursuant to this Agreement, the Recipient (or his/her personal representative) shall deliver to the Company, within ten (10) days after the occurrence of such registration specified above (or in the event of death, within ten
(10) days of the appointment of the personal representative) (a “Payment Date”), either a check payable to the 

  

 4 

 
Company in the amount of all withholding tax obligations (whether federal, state, local or foreign income or social insurance tax), imposed on the Recipient
and the Company by reason of the awarding of the Performance Shares, or a withholding election form to be provided by the Company upon request by the Recipient (or personal representative). 
 (b) In the event the Recipient or his personal representative elects to satisfy the withholding obligation by executing the withholding election
form, the Recipient’s actual number of vested shares of Performance Shares shall be reduced by the smallest number of whole shares of Stock which, when multiplied by the Fair Market Value of the Stock on the Payment Date, is sufficient to
satisfy the amount of the withholding tax obligations imposed on the Company by reason of the Recipient being recorded as the stockholder of record of the earned Performance Shares. In the event that the Recipient fails to tender either the required
certified check or withholding election, the Recipient shall be deemed to have elected and executed the withholding election form. 
 8.
Effect of Changes in Capitalization or Change in Control. 
 (a) Changes in Stock. If the outstanding shares of Stock are
increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of any recapitalization, reclassification, stock split, reverse split, combination of shares, exchange of
shares, stock dividend or other distribution payable in capital stock, or other increase or decrease in such shares effected without receipt of consideration by the Company occurring after the date the Award is granted, then, in the Board’s
discretion, a proportionate and appropriate adjustment may be made by the Board in the number and kind of shares subject to the Award, so that the proportionate interest of the Recipient immediately following such event shall, to the extent
practicable, be the same as immediately prior to such event. In the event of any distribution to the Company’s stockholders of securities of any other entity or other assets (other than dividends payable in cash or stock of the Company) without
receipt of consideration by the Company, the Board shall, in such manner as it deems appropriate, adjust the number and kind of shares subject to the Award to reflect such distribution. 
 (b) Reorganization in Which the Company Is the Surviving Company. Subject to 8(c) below, if the Company shall be the surviving Company in any
reorganization, merger, or consolidation of the Company with one or more other companies or other entities, the Award shall pertain to and apply to the securities to which a holder of the number of shares of Stock subject to the Award would have
been entitled immediately following such reorganization, merger, or consolidation, with a corresponding proportionate adjustment of the Award, as may be applicable so that the aggregate value of the Award thereafter shall be the same as the
aggregate value of the Award immediately before such reorganization, merger, or consolidation. 
 (c) Change in Control. In the event
of a Change in Control, the Board may (i) make provisions in connection with such transaction for the continuation of the Award; (ii) reach an agreement with the acquiring or surviving entity that the acquiring or surviving entity will
assume the obligation of the Company under the Award; (iii) reach an agreement with the acquiring or surviving entity that the acquiring or surviving entity will convert the Award into an award of at least equal value, determined as of the date
of the transaction, to purchase 

  

 5 

 
stock of the acquiring or surviving entity; or (iv) terminate the Award effective upon the date of the applicable transaction and either make, within
sixty (60) days after the date of the applicable transaction, a cash payment to the Recipient equal to product of the number of shares of Stock subject to the Award and the Fair Market Value, as of the date of the applicable transaction, of the
shares of Stock subject to the Award; provided, however, that the Board determines that any such modification does not have a substantial adverse economic impact on the Recipient as determined at the time of such modification. 
 9. General Restrictions. The Company shall not be required to sell or issue any shares of Stock under the Award if the sale or issuance of
such shares would constitute a violation by the Recipient or by the Company of any provision of any law or regulation of any governmental authority, including without limitation any federal or state securities laws or regulations. If at any time the
Company shall determine, in its discretion, that the listing, registration, or qualification of any shares subject to the Award upon any securities exchange or under any state or federal law, or the consent or approval of any government regulatory
body, is necessary or desirable as a condition of, or in connection with, the issuance or purchase of shares, the Award may not be exercised in whole or in part unless such listing, registration, qualification, consent, or approval shall have been
effected or obtained free of any conditions not acceptable to the Company, and any delay caused thereby shall in no way affect the date of termination of the Award. Specifically in connection with the Securities Act of 1933 (as now in effect or as
hereafter amended), unless a registration statement under such Act is in effect with respect to the shares of Stock covered by the Award, the Company shall not be required to sell or issue such shares unless the Company has received evidence
satisfactory to it that the holder of the Award may acquire such shares pursuant to an exemption from registration under such Act. Any determination in this connection by the Company shall be final, binding, and conclusive. The Company may, but
shall in no event be obligated to, register any securities covered hereby pursuant to the Securities Act of 1933 (as now in effect or as hereafter amended). The Company shall not be obligated to take any affirmative action in order to cause the
issuance of shares pursuant to the Award to comply with any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that the Award shall not be exercisable unless and until the shares of Stock
covered by the Award are registered or are subject to an available exemption from registration, the exercise of the Award (under circumstances in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such
registration or the availability of such an exemption. 
 10. Restrictions On Transfer. Other than by will or
under the laws of descent and distribution, the Recipient shall not have the right to make or permit to occur any transfer, pledge or hypothecation of all or any portion of any unvested portion of the Award, whether outright or as security, with or
without consideration, voluntary or involuntary. Any such transfer, pledge or hypothecation not made in accordance with this Agreement shall be deemed null and void. 
 11. Interpretation of this Agreement. All decisions and interpretations made by the Committee or the Board with regard to any question arising under this Agreement shall be final, binding and
conclusive on the Company and the Recipient and any other person entitled to receive the benefits of the Award as provided for herein. 
  

 6 

 12. Governing Law. The validity, interpretation and enforcement of this Agreement
are governed in all respects by the laws of the State of Delaware, without giving effect to its conflict of laws principles, and by the laws of the United States of America. 
 13. Binding Effect. Subject to all restrictions provided for in this Agreement and by applicable law relating to assignment and
transfer of this Agreement and the Award provided for herein, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, executors, administrators, successors, and assigns. 
 14. Notice. Any notice hereunder by the Recipient to the Company shall be in writing and shall be deemed duly given if mailed or
delivered to the Company at its principal office, addressed to the attention of the Board, or if so mailed or delivered to such other address as the Company may hereafter designate by notice to the Recipient. Any notice hereunder by the Company to
the Recipient shall be in writing and shall be deemed duly given if mailed or delivered to the Recipient at the address specified below by the Recipient for such purpose, or if so mailed or delivered to such other address as the Recipient may
hereafter designate by written notice given to the Company. 
 15. Severability. In the event that any one or more of the
provisions or portion thereof contained in this Agreement shall for any reason be held to be invalid, illegal or unenforceable in any respect, the same shall not invalidate or otherwise affect any other provisions of this Agreement, and this
Agreement shall be construed as if the invalid, illegal or unenforceable provision or portion thereof had never been contained herein. 
 16. Entire Agreement. This Agreement constitutes the entire agreement and supersedes all prior understandings and agreements written or oral, of the parties hereto with respect to the subject matter hereof. There is no
representation or statement made by any party on which another party has relied which is not included in this Agreement. Neither this Agreement nor any term hereof may be amended, waived, discharged, or terminated except by a written instrument
signed by the Company and the Recipient; provided, however, that the Company unilaterally may waive any provision hereof in writing to the extent that such waiver does not adversely affect the interests of the Recipient hereunder, but no such waiver
shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof. 
  

 7 

 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement, or caused
this Agreement to be duly executed and delivered on his or its behalf, as of the day and year first above written. 
  

					
	PHARMERICA CORPORATION	 	
			
	BY:	 	  
	 	
			
	DATE:	 	  
	 	
		
	RECIPIENT	 	
		
	  
	 	
			
	DATE:	 	  
	 	
		
	RECIPIENT’S ADDRESS:	 	
		
	  
	 	
		
	  
	 	
		
	  
	 	

 EXHIBIT A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]